SEC Form 4 · accession 0001415889-16-006910
ACADIA PHARMACEUTICALS INC · ACAD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Edmund Harrigan
Director
Period of report
Aug 16, 2016
Accepted (ET)
Aug 18, 2016 · 5:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070494
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 16, 2016 | P | 1,000 | $32.97 | A | 1,000 | D |
Table II — derivative securities
No Table II lines on this filing.